MetLife Investment Management’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-23,710
| Closed | -$427K | – | 2957 |
|
|
2025
Q1 | $427K | Sell |
23,710
-124
| -0.5% | -$2.2K | ﹤0.01% | 1802 |
|
|
2024
Q4 | $416K | Hold |
23,834
| – | – | ﹤0.01% | 1900 |
|
|
2024
Q3 | $274K | Hold |
23,834
| – | – | ﹤0.01% | 2125 |
|
|
2024
Q2 | $270K | Buy |
23,834
+2,187
| +10% | +$29.1K | ﹤0.01% | 2060 |
|
|
2024
Q1 | $310K | Sell |
21,647
-1,967
| -8% | -$27.9K | ﹤0.01% | 1944 |
|
|
2023
Q4 | $324K | Sell |
23,614
-3,437
| -13% | -$36.2K | ﹤0.01% | 1947 |
|
|
2023
Q3 | $220K | Hold |
27,051
| – | – | ﹤0.01% | 2153 |
|
|
2023
Q2 | $205K | Hold |
27,051
| – | – | ﹤0.01% | 2267 |
|
|
2023
Q1 | $216K | Hold |
27,051
| – | – | ﹤0.01% | 2167 |
|
|
2022
Q4 | $307K | Hold |
27,051
| – | – | ﹤0.01% | 1968 |
|
|
2022
Q3 | $236K | Hold |
27,051
| – | – | ﹤0.01% | 2179 |
|
|
2022
Q2 | $269K | Hold |
27,051
| – | – | ﹤0.01% | 2096 |
|
|
2022
Q1 | $272K | Buy |
27,051
+9,778
| +57% | +$104K | ﹤0.01% | 2155 |
|
|
2021
Q4 | $219K | Buy |
17,273
+7,103
| +70% | +$92.5K | ﹤0.01% | 1996 |
|
|
2021
Q3 | $127K | Sell |
10,170
-7,610
| -43% | -$103K | ﹤0.01% | 2335 |
|
|
2021
Q2 | $268K | Hold |
17,780
| – | – | ﹤0.01% | 1966 |
|
|
2021
Q1 | $244K | Hold |
17,780
| – | – | ﹤0.01% | 1943 |
|
|
2020
Q4 | $323K | Buy |
+17,780
| New | +$274K | ﹤0.01% | 1720 |
|
MetLife Investment Management's PTVE Position: Q2 2025 in Review
MetLife Investment Management sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q2 2025, closing a stake of 23,710 shares — an estimated $427K sold.
MetLife Investment Management first reported a position in PTVE in Q4 2020 and held it in 18 quarters. The position peaked at $427K in Q1 2025. 0 funds tracked by Wall St. Rank hold PTVE as of Q2 2025.
- MetLife Investment Management reported no remaining Pactiv Evergreen Inc. Common stock position as of Q2 2025 after selling out during the quarter.
- MetLife Investment Management sold 23,710 Pactiv Evergreen Inc. Common stock shares in Q2 2025, an estimated $427K.
- MetLife Investment Management first reported a position in Pactiv Evergreen Inc. Common stock in Q4 2020 and held it in 18 quarters.
- MetLife Investment Management's Pactiv Evergreen Inc. Common stock position peaked at $427K in Q1 2025.
- 0 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q2 2025.
Based on MetLife Investment Management's 13F filing for Q2 2025, filed 13 Aug 2025.